A trial looking at zilovertamab vedotin and R-CHP for diffuse large B cell lymphoma (waveLINE-011)

This trial is looking at adding zilovertamab vedotin to a combination of cancer drugs called R-CHP. It is comparing this with another drug called polatuzumab vedotin alongside R-CHP.

It is for people who:

• have a specific type of diffuse large B cell lymphoma called germinal centre B cell

• haven’t had treatment yet

You pronounce zilovertamab vedotin as zi-lov-er-ta-mab veh-doh-tin.

You pronounce polatuzumab vedotin as poh-lah-too-zoo-mab veh-doh-tin.